MedicarePartD.guide

A non-government resource built from CMS public data

HIV treatment and prevention on every 2026 California Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 12 stand-alone Part D plans in California cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days

12 plans, cheapest premium first. Scroll sideways for all of them →

HIV treatment and prevention by 2026 California Part D plan
DrugHealthSpring Assurance Rx$0.00/moS5617-158Wellcare Value Script$5.70/moS4802-163Wellcare Classic$6.20/moS4802-094HealthSpring Extra Rx$70.60/moS5617-382SilverScript Choice$103.60/moS5601-064Humana Value Rx Plan$104.60/moS5884-211AARP Medicare Rx Saver from UHC$109.40/moS5921-376Humana Basic Rx Plan$132.20/moS5884-114AARP Medicare Rx Preferred from UHC$165.40/moS5921-413Humana Premier Rx Plan$172.90/moS5884-178Blue Shield Rx Plus$199.70/moS2468-003Blue Shield Rx Enhanced$227.80/moS2468-004
Biktarvybictegravir/emtricitabine/tenofovir alafenamideTier 525%Tier 525%Tier 525%Tier 525%Tier 525%Tier 526%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 531%QL 30/30dTier 533%QL 30/30dTier 525%QL 1/1dTier 533%QL 1/1d
Dovatodolutegravir and lamivudineTier 525%Tier 525%Tier 525%Tier 525%Tier 525%Tier 526%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 531%QL 30/30dTier 533%QL 30/30dTier 525%QL 1/1dTier 533%QL 1/1d
Triumeqabacavir/dolutegravir/lamivudineTier 429%QL 300/30dTier 440%Tier 431%Tier 430%QL 300/30dTier 433%Tier 432%QL 180/30dTier 438%QL 180/30dTier 432%QL 180/30dTier 431%QL 180/30dTier 450%QL 180/30dTier 449%QL 6/1dTier 437%QL 6/1d
Genvoyaelvitegravir/cobicistat/emtricitabine/tenofovir alafenamideTier 525%QL 30/30dTier 525%Tier 525%Tier 525%QL 30/30dTier 525%Tier 526%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 531%QL 30/30dTier 533%QL 30/30dTier 525%QL 1/1dTier 533%QL 1/1d
Odefseyemtricitabine/rilpivirine/tenofovir alafenamideTier 525%QL 30/30dTier 525%Tier 525%Tier 525%QL 30/30dTier 525%Tier 526%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 531%QL 30/30dTier 533%QL 30/30dTier 525%QL 1/1dTier 533%QL 1/1d
Symtuzadarunavir/cobicistat/emtricitabine/tenofovir alafenamideTier 525%Tier 525%Tier 525%Tier 525%Tier 525%Tier 526%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 531%QL 30/30dTier 533%QL 30/30dTier 525%QL 1/1dTier 533%QL 1/1d
Julucadolutegravir and rilpivirineTier 525%Tier 525%Tier 525%Tier 525%Tier 525%Tier 526%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 531%QL 30/30dTier 533%QL 30/30dTier 525%QL 1/1dTier 533%QL 1/1d
Descovyemtricitabine and tenofovir alafenamideTier 525%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 525%Tier 526%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 531%QL 30/30dTier 533%QL 30/30dTier 525%QL 1/1dTier 533%QL 1/1d
Truvadaemtricitabine and tenofovir disoproxilNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
emtricitabine-tenofovirgeneric TruvadaTier 429%QL 30/30dTier 440%QL 30/30dTier 431%QL 30/30dTier 430%QL 30/30dTier 433%QL 30/30dTier 432%QL 30/30dTier 438%QL 30/30dTier 432%QL 30/30dTier 431%QL 30/30dTier 450%QL 30/30dTier 449%QL 1/1dTier 437%QL 1/1d
TivicaydolutegravirTier 429%QL 180/30dTier 525%Tier 525%Tier 430%QL 180/30dTier 525%Tier 526%QL 60/30dTier 525%QL 60/30dTier 525%QL 60/30dTier 531%QL 60/30dTier 533%QL 60/30dTier 449%QL 6/1dTier 437%QL 6/1d

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.